Arrowgrass Capital Partners (US)’s Biogen BIIB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-130,700	Closed	-$41.6M	–	189
2017 Q4	$41.6M	Buy	130,700 +129,093	+8,033%	+$41.4M	0.98%	50
2017 Q3	$50.3M	Sell	1,607 -305	-16%	-$90.3K	0.84%	64
2017 Q2	$51.9M	Buy	1,912 +1,164	+156%	+$308K	0.86%	64
2017 Q1	$20.5M	Sell	748 -436	-37%	-$123K	0.49%	136
2016 Q4	$33.6M	Sell	1,184 -144	-11%	-$42.7K	0.9%	61
2016 Q3	$41.6M	Buy	1,328 +209	+19%	+$61.9K	1.02%	43
2016 Q2	$27.1M	Buy	1,119 +261	+30%	+$68.8K	0.6%	56
2016 Q1	$22.3M	Buy	858 +658	+329%	+$174K	0.46%	65
2015 Q4	$6.13M	Buy	+200	New	+$57.5K	0.12%	141
2015 Q3	–	Sell	-110	Closed	-$4.44M	–	463
2015 Q2	$4.44M	Buy	+110	New	+$44.1K	0.12%	224
2015 Q1	–	Sell	-34,800	Closed	-$11.8M	–	422
2014 Q4	$11.8M	Buy	+34,800	New	+$11.3M	0.32%	70